156 related articles for article (PubMed ID: 34224206)
1. A Fluorometric CYP19A1 (Aromatase) Activity Assay in Live Cells.
Heidary DK; Kriger SM; Hachey AC; Glazer EC
ChemMedChem; 2021 Sep; 16(18):2845-2850. PubMed ID: 34224206
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).
McNulty J; Keskar K; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4586-4589. PubMed ID: 25155384
[TBL] [Abstract][Full Text] [Related]
3. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
Zhou N; Han SY; Zhou F; Li PP
J Ethnopharmacol; 2014 Jul; 154(3):687-95. PubMed ID: 24809288
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
8. Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
Ghosh D; Lo J; Egbuta C
J Med Chem; 2016 Jun; 59(11):5131-48. PubMed ID: 26689671
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
[TBL] [Abstract][Full Text] [Related]
10. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
[TBL] [Abstract][Full Text] [Related]
11. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
12. Towards an Understanding of the Mode of Action of Human Aromatase Activity for Azoles through Quantum Chemical Descriptors-Based Regression and Structure Activity Relationship Modeling Analysis.
Chayawan C; Toma C; Benfenati E; Caballero Alfonso AY
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046297
[TBL] [Abstract][Full Text] [Related]
13. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
[TBL] [Abstract][Full Text] [Related]
14. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
16. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Bonfield K; Amato E; Bankemper T; Agard H; Steller J; Keeler JM; Roy D; McCallum A; Paula S; Ma L
Bioorg Med Chem; 2012 Apr; 20(8):2603-13. PubMed ID: 22444875
[TBL] [Abstract][Full Text] [Related]
17. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women.
Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS
Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666
[TBL] [Abstract][Full Text] [Related]
18. Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
McNulty J; Nielsen AJ; Brown CE; DiFrancesco BR; Vurgun N; Nair JJ; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2013 Nov; 23(22):6060-3. PubMed ID: 24113062
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
Banday AH; Saeed BA; Al-Masoudi NA
Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
